The Success Rate of Cardiopulmonary Resuscitation in Patients Experiencing In-hospital Cardiac Arrest

Sponsor
Udayana University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04786860
Collaborator
(none)
40
2
14
20
1.4

Study Details

Study Description

Brief Summary

Cardiac arrest causes the heart to stop functioning to maintain circulation that provides oxygen to the brain. The global incidence of cardiac arrest is 50 to 60 per 100,000 people per year. The incidence of cardiac arrest in Indonesia in 2016 was 350,000 cases, in which 12% were successfully resuscitated, compared to the global success rate of 24.8%.

Cardiac arrest events urgently require CPR action that is useful to save lives in an emergency. The application of Code Blue aims to reduce the mortality rate and increase the rate of return of spontaneous circulation. The Code Blue team itself includes a set of teams who are trained in the handling of cardiorespiratory arrest.

Condition or Disease Intervention/Treatment Phase
  • Procedure: CPR

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
The Success Rate of Cardiopulmonary Resuscitation in Patients Experiencing In-hospital Cardiac Arrest at Sanglah General Hospital
Actual Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Nov 30, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Outcome Measures

Primary Outcome Measures

  1. Survivors [6-hours after CPR is stopped]

    The number of patients who were successfully converted to ROSC (return of spontaneous circulation)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with in-hospital cardiac arrest that were treated at Sanglah General Hospital
Exclusion Criteria:
  • Patients who upon admission to the hospital already showing cardiac arrest rhythm

  • Patients who were DOA (death-on-arrival)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Prof. Ngoerah General Hospital Denpasar Bali Indonesia 80114
2 Sanglah General Hospital Denpasar Bali Indonesia 80114

Sponsors and Collaborators

  • Udayana University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christopher Ryalino, MD, Principal Investigator, Udayana University
ClinicalTrials.gov Identifier:
NCT04786860
Other Study ID Numbers:
  • UNUD-CTR-FK210321-001
First Posted:
Mar 8, 2021
Last Update Posted:
Aug 10, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christopher Ryalino, MD, Principal Investigator, Udayana University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2022